Regulatory, legal and policy aspects

Workpackage #8

Regulatory, legal and policy aspects

iCARE4CVD’s vision to pave the way to better care for individuals with
CVD could not be realised without careful insight into the regulatory, legal,
reimbursement, and policy landscape relevant to CVD. By defining a
roadmap, framework, and a strategy for biomarker and medical AI
developments that is safe, ethical, and successful, WP8 will aim to
facilitate a successful adaption and implementation of iCARE4CVD’s
medical tools.

Meet our team

TNO

Robin Mischa van Stokkum

Researcher Digital Health and Coordinator TNO Health & Work AI Lab
Kirsten Budig

Novo Nordisk

Kirsten Budig

Senior Public Affairs Manager

Scientific Institute for Health Economics and Health Systems Research

Ines Weinhold

Managing Director at WIG2

WIG2

Rebekka Mumm

Head of Health Economics

WIG2

Franziska Theile

Research Associate

TNO

Gabriela Bodea, MA

Dutch Organisation for Applied Research
Get updated

Our related news

2 April, 2026

Connecting Health Data for Better Heart Failure Monitoring (SWAT4HCLS conference)

At the SWAT4HCLS conference, iCARE4CVD presented new research introducing the Digital Biomarker..

15 January, 2026

CMEO: making heart disease and clinical studies easier to find, compare, and reuse

Across Europe, vast amounts of heart disease data already exist—but they are..

15 January, 2026

Beyond medical results: Using Patient-Reported Outcomes and Experiences in heart care – a scoping review

In a recent scoping review, we examined 390 studies to understand how..

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.